Suppr超能文献

系统评价儿科吗啡群体模型的描述性和预测性性能。

Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models.

机构信息

Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden, The Netherlands.

出版信息

Pharm Res. 2011 Apr;28(4):797-811. doi: 10.1007/s11095-010-0333-1. Epub 2010 Dec 14.

Abstract

PURPOSE

A framework for the evaluation of paediatric population models is proposed and applied to two different paediatric population pharmacokinetic models for morphine. One covariate model was based on a systematic covariate analysis, the other on fixed allometric scaling principles.

METHODS

The six evaluation criteria in the framework were 1) number of parameters and condition number, 2) numerical diagnostics, 3) prediction-based diagnostics, 4) η-shrinkage, 5) simulation-based diagnostics, 6) diagnostics of individual and population parameter estimates versus covariates, including measurements of bias and precision of the population values compared to the observed individual values. The framework entails both an internal and external model evaluation procedure.

RESULTS

The application of the framework to the two models resulted in the detection of overparameterization and misleading diagnostics based on individual predictions caused by high shrinkage. The diagnostic of individual and population parameter estimates versus covariates proved to be highly informative in assessing obtained covariate relationships. Based on the framework, the systematic covariate model proved to be superior over the fixed allometric model in terms of predictive performance.

CONCLUSIONS

The proposed framework is suitable for the evaluation of paediatric (covariate) models and should be applied to corroborate the descriptive and predictive properties of these models.

摘要

目的

提出了一种用于评估儿科群体模型的框架,并将其应用于两种不同的吗啡儿科群体药代动力学模型。一个协变量模型基于系统协变量分析,另一个基于固定的体表面积比例缩放原则。

方法

该框架中的六个评估标准为:1)参数数量和条件数;2)数值诊断;3)基于预测的诊断;4)η 收缩;5)基于模拟的诊断;6)个体和群体参数估计与协变量的诊断,包括与观察到的个体值相比,对群体值的偏倚和精度的测量。该框架需要内部和外部模型评估过程。

结果

将该框架应用于这两个模型,结果发现由于高收缩导致参数过度拟合和基于个体预测的误导性诊断。个体和群体参数估计与协变量的诊断在评估获得的协变量关系方面非常有信息量。基于该框架,系统协变量模型在预测性能方面优于固定体表面积模型。

结论

所提出的框架适用于儿科(协变量)模型的评估,应应用于证实这些模型的描述性和预测性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565d/3063866/79b156718e86/11095_2010_333_Fig1_HTML.jpg

相似文献

1
Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models.
Pharm Res. 2011 Apr;28(4):797-811. doi: 10.1007/s11095-010-0333-1. Epub 2010 Dec 14.
5
Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
J Clin Pharm Ther. 2021 Jun;46(3):820-831. doi: 10.1111/jcpt.13363. Epub 2021 Mar 22.
7
Prediction of morphine dose in humans.
Paediatr Anaesth. 2012 Mar;22(3):209-22. doi: 10.1111/j.1460-9592.2011.03782.x. Epub 2011 Dec 28.
8
External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates.
Br J Clin Pharmacol. 2021 Oct;87(10):3878-3889. doi: 10.1111/bcp.14803. Epub 2021 Mar 12.
10
Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
Clin Pharmacokinet. 2017 Mar;56(3):273-285. doi: 10.1007/s40262-016-0436-x.

引用本文的文献

1
Scoping Review of Paediatric Population Pharmacokinetic Models of Morphine.
Clin Pharmacokinet. 2025 May 1. doi: 10.1007/s40262-025-01477-5.
3
Use of Antibiotics in Preterm Newborns.
Antibiotics (Basel). 2022 Aug 23;11(9):1142. doi: 10.3390/antibiotics11091142.
4
Quantifying the Pharmacodynamics of Morphine in the Treatment of Postoperative Pain in Preverbal Children.
J Clin Pharmacol. 2022 Jan;62(1):99-109. doi: 10.1002/jcph.1952. Epub 2021 Sep 17.
5
Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.
Clin Transl Sci. 2021 Jul;14(4):1231-1249. doi: 10.1111/cts.12994. Epub 2021 May 1.
6
Electronic Health Record-Embedded Decision Support Platform for Morphine Precision Dosing in Neonates.
Clin Pharmacol Ther. 2020 Jan;107(1):186-194. doi: 10.1002/cpt.1684. Epub 2019 Dec 11.
8
A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.
Naunyn Schmiedebergs Arch Pharmacol. 2019 Sep;392(9):1097-1106. doi: 10.1007/s00210-019-01647-w. Epub 2019 May 6.

本文引用的文献

1
Curvature in metabolic scaling.
Nature. 2010 Apr 1;464(7289):753-6. doi: 10.1038/nature08920.
2
The role of population PK-PD modelling in paediatric clinical research.
Eur J Clin Pharmacol. 2011 May;67 Suppl 1(Suppl 1):5-16. doi: 10.1007/s00228-009-0782-9. Epub 2010 Mar 26.
3
Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.
Clin Pharmacokinet. 2009;48(6):371-85. doi: 10.2165/00003088-200948060-00003.
4
Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.
AAPS J. 2009 Sep;11(3):558-69. doi: 10.1208/s12248-009-9133-0. Epub 2009 Aug 1.
5
Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept.
Drug Metabol Drug Interact. 2009;24(1):57-81. doi: 10.1515/dmdi.2009.24.1.57.
6
Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.
Br J Anaesth. 2008 Nov;101(5):680-9. doi: 10.1093/bja/aen248. Epub 2008 Aug 23.
7
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comput Methods Programs Biomed. 2008 May;90(2):154-66. doi: 10.1016/j.cmpb.2007.12.002. Epub 2008 Jan 22.
8
Mechanism-based concepts of size and maturity in pharmacokinetics.
Annu Rev Pharmacol Toxicol. 2008;48:303-32. doi: 10.1146/annurev.pharmtox.48.113006.094708.
9
Diagnosing model diagnostics.
Clin Pharmacol Ther. 2007 Jul;82(1):17-20. doi: 10.1038/sj.clpt.6100241.
10
Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
Ther Drug Monit. 2007 Jun;29(3):271-8. doi: 10.1097/FTD.0b013e318042d3c4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验